Sodium Chloride
(FAPWRFPIFSIZLT-UHFFFAOYSA-M)
Structure
- SMILES
- [Na+].[Cl-]
- Type(s)
- Approved; Vet_approved
- ATC code(s)
- A12CA01; B05CB01; B05XA03
- Molecular Formula:
- ClNa
- Molecular Weight:
- 58.443
- Log P:
- -2.9960
- Hydrogen Bond Acceptor:
- 0
- Hydrogen Bond Donor:
- 0
- TPSA:
- 0
- CAS Number(s):
- 7647-14-5; 14762-51-7; 32343-72-9
Synonym(s)
1.
Sodium Chloride
2.
Sodium Chloride, (22)Na
3.
Sodium Chloride, (24)NaCl
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Chills | FAERS: 20 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 2 | Cardiac Arrest | FAERS: 14 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 3 | Nausea | FAERS: 14 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 4 | Vomiting | FAERS: 13 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 5 | Medication Error | FAERS: 12 | US FAERS | |
| 6 | Chest Pain | FAERS: 11 | US FAERS | |
| 7 | Erythema | FAERS: 11 | US FAERS | |
| 8 | No adverse event | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 9 | Headache | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 10 | Sepsis | FAERS: 10 Canada Vigilance: 10 | Canada Vigilance US FAERS | |
| 11 | Tremor | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 12 | Anxiety | FAERS: 8 | US FAERS | |
| 13 | Dizziness | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 14 | Pharmaceutical product complaint | FAERS: 8 | US FAERS | |
| 15 | Air Embolism | FAERS: 7 | US FAERS | |
| 16 | Asthenia | FAERS: 7 | US FAERS | |
| 17 | Burning sensation | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 18 | Cyanosis | FAERS: 7 | US FAERS | |
| 19 | Hypotension | FAERS: 7 | US FAERS | |
| 20 | Injection site pain | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 21 | Malaise | FAERS: 7 | US FAERS | |
| 22 | Osmotic demyelination syndrome | FAERS: 7 | US FAERS | |
| 23 | Product quality issue | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 24 | Back Pain | FAERS: 6 | US FAERS | |
| 25 | Chest discomfort | FAERS: 6 | US FAERS | |
| 26 | Incorrect product formulation administered | FAERS: 6 | US FAERS | |
| 27 | Infusion Site Extravasation | FAERS: 6 | US FAERS | |
| 28 | Product contamination physical | FAERS: 6 | US FAERS | |
| 29 | Product use issue | FAERS: 6 | US FAERS | |
| 30 | Shock | FAERS: 6 | US FAERS | |
| 31 | Circumstance or information capable of leading to medication error | FAERS: 5 | US FAERS | |
| 32 | Discomfort | FAERS: 5 | US FAERS | |
| 33 | Incorrect route of drug administration | FAERS: 5 | US FAERS | |
| 34 | Injection site vesicles | FAERS: 5 | US FAERS | |
| 35 | Pruritus | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 36 | Urticaria | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 37 | Wrong drug administered | FAERS: 5 | US FAERS | |
| 38 | Fluid overload | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 39 | Incorrect dose administered | FAERS: 4 | US FAERS | |
| 40 | Infection | FAERS: 4 | US FAERS | |
| 41 | Poor quality drug administered | FAERS: 4 | US FAERS | |
| 42 | Product distribution issue | FAERS: 4 | US FAERS | |
| 43 | Tachycardia | FAERS: 4 | US FAERS | |
| 44 | Venous oxygen saturation decreased | FAERS: 4 | US FAERS | |
| 45 | Accidental exposure | FAERS: 3 | US FAERS | |
| 46 | Anaphylactoid Reaction | FAERS: 3 | US FAERS | |
| 47 | Dehydration | FAERS: 3 | US FAERS | |
| 48 | Device breakage | FAERS: 3 | US FAERS | |
| 49 | Fatigue | FAERS: 3 | US FAERS | |
| 50 | Feeling abnormal | FAERS: 3 | US FAERS | |
| 51 | Incorrect drug administration rate | FAERS: 3 | US FAERS | |
| 52 | Infusion site swelling | FAERS: 3 | US FAERS | |
| 53 | Intentional product misuse | FAERS: 3 | US FAERS | |
| 54 | Metabolic acidosis | FAERS: 3 | US FAERS | |
| 55 | Myocardial Infarction | FAERS: 3 | US FAERS | |
| 56 | Neck Pain | FAERS: 3 | US FAERS | |
| 57 | Pain | FAERS: 3 Canada Vigilance: 1 | 14981739 | CTD Canada Vigilance US FAERS |
| 58 | Palpitations | FAERS: 3 | US FAERS | |
| 59 | Post procedural complication | FAERS: 3 | US FAERS | |
| 60 | Product container issue | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 61 | Product contamination microbial | FAERS: 3 | US FAERS | |
| 62 | Transurethral resection syndrome | FAERS: 3 | US FAERS | |
| 63 | Accidental exposure to product | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 64 | Altered state of consciousness | FAERS: 2 | US FAERS | |
| 65 | Arthralgia | FAERS: 2 | US FAERS | |
| 66 | Bronchospasm | FAERS: 2 | US FAERS | |
| 67 | Cerebral disorder | FAERS: 2 | US FAERS | |
| 68 | Device kink | FAERS: 2 | US FAERS | |
| 69 | Device related infection | FAERS: 2 | US FAERS | |
| 70 | Drug dispensing error | FAERS: 2 | US FAERS | |
| 71 | Dysarthria | FAERS: 2 | US FAERS | |
| 72 | Dysgeusia | FAERS: 2 | US FAERS | |
| 73 | Expired drug administered | FAERS: 2 | US FAERS | |
| 74 | Eye pain | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 75 | Flushing | FAERS: 2 | US FAERS | |
| 76 | Incorrect drug administration duration | FAERS: 2 | US FAERS | |
| 77 | Incorrect product storage | FAERS: 2 | US FAERS | |
| 78 | Injection site irritation | FAERS: 2 | US FAERS | |
| 79 | Liquid product physical issue | FAERS: 2 | US FAERS | |
| 80 | Meningitis | FAERS: 2 | US FAERS | |
| 81 | Muscle Rigidity | FAERS: 2 | US FAERS | |
| 82 | Peripheral swelling | FAERS: 2 | US FAERS | |
| 83 | Product barcode issue | FAERS: 2 | US FAERS | |
| 84 | Product label confusion | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 85 | Product selection error | FAERS: 2 | US FAERS | |
| 86 | Product substitution issue | FAERS: 2 | US FAERS | |
| 87 | Product use in unapproved indication | FAERS: 2 | US FAERS | |
| 88 | Syncope | FAERS: 2 | US FAERS | |
| 89 | Unevaluable event | FAERS: 2 | US FAERS | |
| 90 | Unresponsive to stimuli | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 91 | Wrong technique in drug usage process | FAERS: 2 | US FAERS | |
| 92 | Accidental overdose | FAERS: 1 | US FAERS | |
| 93 | Angina Pectoris | FAERS: 1 | US FAERS | |
| 94 | Apparent death | FAERS: 1 | US FAERS | |
| 95 | Ataxia | FAERS: 1 | US FAERS | |
| 96 | Bacterial test positive | FAERS: 1 | US FAERS | |
| 97 | Blood creatinine increased | FAERS: 1 | US FAERS | |
| 98 | Blood potassium decreased | FAERS: 1 | US FAERS | |
| 99 | Blood sodium abnormal | FAERS: 1 | US FAERS | |
| 100 | Blood sodium decreased | FAERS: 1 | US FAERS | |
| 101 | Bradycardia | FAERS: 1 | US FAERS | |
| 102 | Cataract operation | FAERS: 1 | US FAERS | |
| 103 | Cellulitis of male external genital organ | FAERS: 1 | US FAERS | |
| 104 | Cerebral Thrombosis | FAERS: 1 | US FAERS | |
| 105 | Choking | FAERS: 1 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 106 | Cold sweat | FAERS: 1 | US FAERS | |
| 107 | Constipation | FAERS: 1 | US FAERS | |
| 108 | Conversion disorder | FAERS: 1 | US FAERS | |
| 109 | Crying | FAERS: 1 | US FAERS | |
| 110 | Demyelination | FAERS: 1 | US FAERS | |
| 111 | Device Failure | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 112 | Device leakage | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 113 | Device malfunction | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 114 | Device occlusion | FAERS: 1 | US FAERS | |
| 115 | Device programming error | FAERS: 1 | US FAERS | |
| 116 | Diabetic Ketoacidosis | FAERS: 1 | US FAERS | |
| 117 | Dilutional coagulopathy | FAERS: 1 | US FAERS | |
| 118 | Disseminated Intravascular Coagulation | FAERS: 1 | US FAERS | |
| 119 | Drug administration error | FAERS: 1 | US FAERS | |
| 120 | Drug effect incomplete | FAERS: 1 | US FAERS | |
| 121 | Drug exposure during pregnancy | FAERS: 1 | US FAERS | |
| 122 | Drug ineffective | FAERS: 1 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 123 | Drug ineffective for unapproved indication | FAERS: 1 | US FAERS | |
| 124 | Drug prescribing error | FAERS: 1 | US FAERS | |
| 125 | Dysphonia | FAERS: 1 | US FAERS | |
| 126 | Electrolyte imbalance | FAERS: 1 | US FAERS | |
| 127 | Endophthalmitis | FAERS: 1 | US FAERS | |
| 128 | Epicondylitis | FAERS: 1 | US FAERS | |
| 129 | Exophthalmos | FAERS: 1 | US FAERS | |
| 130 | Exposure to toxic agent | FAERS: 1 | US FAERS | |
| 131 | Facial paralysis | FAERS: 1 | US FAERS | |
| 132 | Flank Pain | FAERS: 1 | US FAERS | |
| 133 | Foreign body sensation in eyes | FAERS: 1 | US FAERS | |
| 134 | General physical health deterioration | FAERS: 1 | US FAERS | |
| 135 | Hypercapnia | FAERS: 1 | US FAERS | |
| 136 | Hypersensitivity | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 137 | Hyperthyroidism | FAERS: 1 | US FAERS | |
| 138 | Inflammation | FAERS: 1 | US FAERS | |
| 139 | Injection Site Reaction | FAERS: 1 | US FAERS | |
| 140 | Injection site erythema | FAERS: 1 | US FAERS | |
| 141 | Intercepted drug administration error | FAERS: 1 | US FAERS | |
| 142 | Joint swelling | FAERS: 1 | US FAERS | |
| 143 | Laboratory test interference | FAERS: 1 | US FAERS | |
| 144 | Lower respiratory tract infection | FAERS: 1 | US FAERS | |
| 145 | Maternal exposure during pregnancy | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 146 | Mental status changes | FAERS: 1 | US FAERS | |
| 147 | Multi-organ disorder | FAERS: 1 | US FAERS | |
| 148 | Musculoskeletal Pain | FAERS: 1 | US FAERS | |
| 149 | Mydriasis | FAERS: 1 | US FAERS | |
| 150 | Nasal discomfort | FAERS: 1 | US FAERS | |
| 151 | Nasopharyngitis | FAERS: 1 | US FAERS | |
| 152 | Near Drowning | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 153 | Necrosis | FAERS: 1 | US FAERS | |
| 154 | Oliguria | FAERS: 1 | US FAERS | |
| 155 | Overdose | FAERS: 1 | US FAERS | |
| 156 | Pallor | FAERS: 1 | US FAERS | |
| 157 | Peritonitis | FAERS: 1 | US FAERS | |
| 158 | Photophobia | FAERS: 1 | US FAERS | |
| 159 | Physical product label issue | FAERS: 1 | US FAERS | |
| 160 | Pneumonia | FAERS: 1 | US FAERS | |
| 161 | Pneumothorax | FAERS: 1 | US FAERS | |
| 162 | Post procedural infection | FAERS: 1 | US FAERS | |
| 163 | Procedural complication | FAERS: 1 | US FAERS | |
| 164 | Product container seal issue | FAERS: 1 | US FAERS | |
| 165 | Product contamination | FAERS: 1 | US FAERS | |
| 166 | Product deposit | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 167 | Product label issue | FAERS: 1 | US FAERS | |
| 168 | Product packaging quantity issue | FAERS: 1 | US FAERS | |
| 169 | Product physical issue | FAERS: 1 | US FAERS | |
| 170 | Product preparation error | FAERS: 1 | US FAERS | |
| 171 | Product preparation issue | FAERS: 1 | US FAERS | |
| 172 | Product prescribing error | FAERS: 1 | US FAERS | |
| 173 | Product storage error | FAERS: 1 | US FAERS | |
| 174 | Pyelonephritis | FAERS: 1 | US FAERS | |
| 175 | Quadriplegia | FAERS: 1 | US FAERS | |
| 176 | Rales | FAERS: 1 | US FAERS | |
| 177 | Reaction to excipient | FAERS: 1 | US FAERS | |
| 178 | Respiratory arrest | FAERS: 1 | US FAERS | |
| 179 | Retrograde amnesia | FAERS: 1 | US FAERS | |
| 180 | Screaming | FAERS: 1 | US FAERS | |
| 181 | Septic Shock | FAERS: 1 | US FAERS | |
| 182 | Skin Ulcer | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 183 | Soft tissue necrosis | FAERS: 1 | US FAERS | |
| 184 | Systemic Inflammatory Response Syndrome | FAERS: 1 | US FAERS | |
| 185 | Tetany | FAERS: 1 | US FAERS | |
| 186 | Therapy change | FAERS: 1 | US FAERS | |
| 187 | Thermal burn | FAERS: 1 | US FAERS | |
| 188 | Throat irritation | FAERS: 1 | US FAERS | |
| 189 | Thrombosis in device | FAERS: 1 | US FAERS | |
| 190 | Toxicity to various agents | FAERS: 1 | US FAERS | |
| 191 | Transcription medication error | FAERS: 1 | US FAERS | |
| 192 | Transfusion Reaction | FAERS: 1 | US FAERS | |
| 193 | Venous Thrombosis | FAERS: 1 | US FAERS | |
| 194 | Visual Impairment | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 195 | Wheezing | FAERS: 1 | US FAERS | |
| 196 | Wrist deformity | FAERS: 1 | US FAERS | |
| 197 | Wrong technique in product usage process | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 198 | nervous system disorder | FAERS: 1 | US FAERS | |
| 199 | Abdominal discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 200 | Acute kidney injury | 618599 3547511 16878259 | CTD | |
| 201 | Acute sinusitis | Canada Vigilance: 1 | Canada Vigilance | |
| 202 | Adenocarcinoma | 7821872 | CTD | |
| 203 | Adverse event | Canada Vigilance: 1 | Canada Vigilance | |
| 204 | Angioedema | Canada Vigilance: 1 | Canada Vigilance | |
| 205 | Arteriovenous fistula site complication | Canada Vigilance: 1 | Canada Vigilance | |
| 206 | Cardiomegaly | 9353849 17325658 | CTD | |
| 207 | Choledochal Cyst | 18988797 | CTD | |
| 208 | Device damage | Canada Vigilance: 1 | Canada Vigilance | |
| 209 | Device ineffective | Canada Vigilance: 1 | Canada Vigilance | |
| 210 | Edema | 5067144 | CTD | |
| 211 | Electrolyte depletion | Canada Vigilance: 1 | Canada Vigilance | |
| 212 | Epistaxis | Canada Vigilance: 2 | Canada Vigilance | |
| 213 | Extravasation of Diagnostic and Therapeutic Materials | 7706905 | CTD | |
| 214 | Feeling Cold | Canada Vigilance: 2 | Canada Vigilance | |
| 215 | Fetal Death | 5067144 | CTD | |
| 216 | Flatulence | Canada Vigilance: 1 | Canada Vigilance | |
| 217 | Gastrointestinal sounds abnormal | Canada Vigilance: 1 | Canada Vigilance | |
| 218 | Hyperalgesia | 27231091 | CTD | |
| 219 | Hypercalcemia | 8483820 | CTD | |
| 220 | Hyperemia | 10564113 | CTD | |
| 221 | Hyponatremia | 6407273 16633772 | CTD | |
| 222 | Kidney Diseases | CTD | ||
| 223 | Leishmaniasis, Cutaneous | 9499605 | CTD | |
| 224 | Musculoskeletal chest pain | Canada Vigilance: 1 | Canada Vigilance | |
| 225 | Patient-device incompatibility | Canada Vigilance: 1 | Canada Vigilance | |
| 226 | Polyuria | 20649851 | CTD | |
| 227 | Product complaint | Canada Vigilance: 1 | Canada Vigilance | |
| 228 | Product formulation issue | Canada Vigilance: 1 | Canada Vigilance | |
| 229 | Product taste abnormal | Canada Vigilance: 2 | Canada Vigilance | |
| 230 | Product use complaint | Canada Vigilance: 2 | Canada Vigilance | |
| 231 | Proteinuria | 2369495 | CTD | |
| 232 | Retinal Detachment | Canada Vigilance: 1 | Canada Vigilance | |
| 233 | Seizures | 5067144 11824763 | CTD | |
| 234 | Sick Sinus Syndrome | 2790295 | CTD | |
| 235 | Stomach Diseases | 11567657 | CTD | |
| 236 | Stomach Neoplasms | 7821872 16646055 | CTD | |
| 237 | Swelling | Canada Vigilance: 1 | Canada Vigilance | |
| 238 | Tachycardia, Ventricular | 2790295 | CTD | |
| 239 | Therapeutic product effect decreased | Canada Vigilance: 1 | Canada Vigilance | |
| 240 | Tinnitus | Canada Vigilance: 1 | Canada Vigilance | |
| 241 | Vascular Remodeling | 27678262 | CTD | |
| 242 | Ventricular Fibrillation | 2790295 3372179 10823730 | CTD | |
| 243 | Water Intoxication | 803783 5067144 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.